In summary, we have highlighted six promising paths to finding an effective treatment for KRAS-mutant pancreatic cancer: targeting KRAS directly, upsetting its membrane association, exploiting synthetic lethal interactions, targeting the pathways downstream of KRAS, pursuing the metabolic processes that KRAS regulates, and harnessing the immune response. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.